<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38317218</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1465-993X</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>05</Day></PubDate></JournalIssue><Title>Respiratory research</Title><ISOAbbreviation>Respir Res</ISOAbbreviation></Journal><ArticleTitle>Viral coinfection in hospitalized patients during the COVID-19 pandemic in Southern Brazil: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>71</StartPage><MedlinePgn>71</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">71</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12931-024-02708-2</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Since the worldwide spread of SARS-CoV-2, different strategies have been followed to combat the pandemic and limit virus transmission. In the meantime, other respiratory viruses continued to circulate, though at decreased rates.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study was conducted between June and July 2022, in a hospital in the metropolitan region of Rio Grande do Sul state, in the southernmost state of Brazil. The 337 hospitalized patients included those with respiratory symptoms without delimitation of age. Reverse transcription-quantitative real-time polymerase chain reaction detected 15 different respiratory viruses and confirmed coinfections in the samples. Different statistical tests were applied to evaluate the association between associations of clinical characteristics and coinfection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sampling corresponds to 337 selected and 330 patients analyzed. The principal clinical outcome found was hospital discharge in 309 (94%) cases, while 21 (6%) resulted in death. The principal viral agents related to coinfections were Human rhinovirus, Human enterovirus, and Respiratory syncytial virus. The most frequent viral agent detected was SARS-CoV-2, with 60 (18%) infections, followed by 51 (15%) cases of Respiratory syncytial virus B (15%) and 44 (13%) cases of Human rhinovirus 1. Coinfection was mainly observed in children, while adults and the elderly were more affected by a single infection. Analyzing COVID-19 vaccination, 175 (53%) were unvaccinated while the remainder had at least one dose of the vaccine.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study presents information to update the understanding of viral circulation in the region. Furthermore, the findings clarify the behavior of viral infections and possible coinfections in hospitalized patients, considering different ages and clinical profiles. In addition, this knowledge can help to monitor the population's clinical manifestations and prevent future outbreaks of respiratory viruses.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rhoden</LastName><ForeName>Jaqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratório de Microbiologia Molecular, Universidade Feevale, Rodovia ERS-239, N◦ 2755, Prédio Vermelho, Piso 1, Sala 103, Vila Nova, Novo Hamburgo, Rio Grande Do Sul, CEP 93525-075, Brazil. jaqueline.rhodenjr@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Santa Casa de Misericórdia de Porto Alegre, Hospital Dom Vicente Scherer, Centro Histórico, Av. Independência, Nº 155, Porto Alegre, Rio Grande Do Sul, CEP 90035- 074, Brazil. jaqueline.rhodenjr@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>Andressa Taíz</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Santa Casa de Misericórdia de Porto Alegre, Hospital Dom Vicente Scherer, Centro Histórico, Av. Independência, Nº 155, Porto Alegre, Rio Grande Do Sul, CEP 90035- 074, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stein</LastName><ForeName>Janaína Franciele</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Laboratório de Microbiologia Molecular, Universidade Feevale, Rodovia ERS-239, N◦ 2755, Prédio Vermelho, Piso 1, Sala 103, Vila Nova, Novo Hamburgo, Rio Grande Do Sul, CEP 93525-075, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocha</LastName><ForeName>Bruna Seixas da</ForeName><Initials>BSD</Initials><AffiliationInfo><Affiliation>Laboratório de Microbiologia Molecular, Universidade Feevale, Rodovia ERS-239, N◦ 2755, Prédio Vermelho, Piso 1, Sala 103, Vila Nova, Novo Hamburgo, Rio Grande Do Sul, CEP 93525-075, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barros</LastName><ForeName>Vinícius Monteagudo de</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Laboratório de Microbiologia Molecular, Universidade Feevale, Rodovia ERS-239, N◦ 2755, Prédio Vermelho, Piso 1, Sala 103, Vila Nova, Novo Hamburgo, Rio Grande Do Sul, CEP 93525-075, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Eduardo Viegas da</ForeName><Initials>EVD</Initials><AffiliationInfo><Affiliation>Centro Estadual de Vigilância em Saúde do Rio Grande Do Sul, Av. Ipiranga, 5400, Jardim Botânico, Porto Alegre, Rio Grande Do Sul, CEP 90450-190, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleck</LastName><ForeName>Juliane Deise</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Laboratório de Microbiologia Molecular, Universidade Feevale, Rodovia ERS-239, N◦ 2755, Prédio Vermelho, Piso 1, Sala 103, Vila Nova, Novo Hamburgo, Rio Grande Do Sul, CEP 93525-075, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rigotto</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratório de Microbiologia Molecular, Universidade Feevale, Rodovia ERS-239, N◦ 2755, Prédio Vermelho, Piso 1, Sala 103, Vila Nova, Novo Hamburgo, Rio Grande Do Sul, CEP 93525-075, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Respir Res</MedlineTA><NlmUniqueID>101090633</NlmUniqueID><ISSNLinking>1465-9921</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018113" MajorTopicYN="Y">Respiratory Syncytial Virus, Human</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Infections</Keyword><Keyword MajorTopicYN="N">Respiratory viruses</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword></KeywordList><CoiStatement>The authors have no relevant financial or non-financial interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>6</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>5</Day><Hour>23</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38317218</ArticleId><ArticleId IdType="pmc">PMC10840208</ArticleId><ArticleId IdType="doi">10.1186/s12931-024-02708-2</ArticleId><ArticleId IdType="pii">10.1186/s12931-024-02708-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moriyama M, Hugentobler WJ, Iwasaki A. Seasonality of respiratory viral infections. Annu Rev Virol. 2020;7:83–101. doi: 10.1146/annurev-virology-012420-022445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-012420-022445</ArticleId><ArticleId IdType="pubmed">32196426</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens DM, Fauci AS. Emerging pandemic diseases: how we got to COVID-19. Cell. 2020;182:1077–1092. doi: 10.1016/j.cell.2020.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.021</ArticleId><ArticleId IdType="pmc">PMC7428724</ArticleId><ArticleId IdType="pubmed">32846157</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, et al. COVID-19: a global challenge with old history, epidemiology and progress so far. Moléculas. 2021;26(1):1–25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7795815</ArticleId><ArticleId IdType="pubmed">33374759</ArticleId></ArticleIdList></Reference><Reference><Citation>Redlberger-Fritz M, Kundi M, Aberle SW, Puchhammer-Stöckl E. Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria. J Clin Virol. 2021 doi: 10.1016/j.jcv.2021.104795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2021.104795</ArticleId><ArticleId IdType="pmc">PMC7962988</ArticleId><ArticleId IdType="pubmed">33761423</ArticleId></ArticleIdList></Reference><Reference><Citation>Marriott D, Beresford R, Mirdad F, Stark D, Glanville A, Chapman S, et al. Concomitant marked decline in prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other respiratory viruses among symptomatic patients following public health interventions in Australia: data from St Vincent’s Hospital and associated screening clinics, Sydney, NSW. Clin Infect Dis. 2021 doi: 10.1093/cid/ciaa1256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1256</ArticleId><ArticleId IdType="pmc">PMC7499558</ArticleId><ArticleId IdType="pubmed">32841316</ArticleId></ArticleIdList></Reference><Reference><Citation>Krumbein H, Kümmel LS, Fragkou PC, Thölken C, Hünerbein BL, Reiter R, et al. Respiratory viral co-infections in patients with COVID-19 and associated outcomes: a systematic review and meta-analysis. Rev Med Virol. 2023 doi: 10.1002/rmv.2365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2365</ArticleId><ArticleId IdType="pmc">PMC9347814</ArticleId><ArticleId IdType="pubmed">35686619</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen AKA, Gularte JS, Demoliner M, de Abreu Goés Pereira VM, Heldt FH, Filippi M, et al. Low circulation of Influenza A and coinfection with SARS-CoV-2 among other respiratory viruses during the COVID-19 pandemic in a region of southern Brazil. J Med Virol. 2021;93:4392–8. doi: 10.1002/jmv.26975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26975</ArticleId><ArticleId IdType="pmc">PMC8250881</ArticleId><ArticleId IdType="pubmed">33829531</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren L, Lin L, Zhang H, Wang Q, Cheng Y, Liu Q, et al. Epidemiological and clinical characteristics of respiratory syncytial virus and influenza infections in hospitalized children before and during the COVID-19 pandemic in Central China. Influenza Other Respir Viruses. 2023;17:1–11. doi: 10.1111/irv.13103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.13103</ArticleId><ArticleId IdType="pmc">PMC9895987</ArticleId><ArticleId IdType="pubmed">36824393</ArticleId></ArticleIdList></Reference><Reference><Citation>Troeger C, Blacker B, Khalil IA, Rao PC, Cao J, Zimsen SRM, et al. Estimates of the global, regional, and national morbidity, mortality, and etiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18:1191–1210. doi: 10.1016/S1473-3099(18)30310-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30310-4</ArticleId><ArticleId IdType="pmc">PMC6202443</ArticleId><ArticleId IdType="pubmed">30243584</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg EM, Hasegawa K, Lawrence A, Kline JA, Camargo CA, Aufderheide T, et al. Viral coinfection is associated with improved outcomes in emergency department patients with SARS-CoV-2. West J Emerg Med. 2021;22:1262–1269. doi: 10.5811/WESTJEM.2021.8.53590.</Citation><ArticleIdList><ArticleId IdType="doi">10.5811/WESTJEM.2021.8.53590</ArticleId><ArticleId IdType="pmc">PMC8597701</ArticleId><ArticleId IdType="pubmed">34787549</ArticleId></ArticleIdList></Reference><Reference><Citation>Mary De Paiva K, Hillesheim D, Rech CR, Delevatti RS, Vasconi R, Brown S, et al. Prevalência e Fatores Associados à SRAG por COVID-19 em Adultos e Idosos com Doença Cardiovascular Crônica. Arq Bras Cardiol. 2021;117:968–75. doi: 10.36660/abc.20200955.</Citation><ArticleIdList><ArticleId IdType="doi">10.36660/abc.20200955</ArticleId><ArticleId IdType="pmc">PMC8682099</ArticleId><ArticleId IdType="pubmed">34161421</ArticleId></ArticleIdList></Reference><Reference><Citation>de Steenhuijsen Piters WA, Binkowska J, Bogaert D. Early life microbiota and respiratory tract infections. Cell Host Microbe. 2020;28:223–32. doi: 10.1016/j.chom.2020.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.07.004</ArticleId><ArticleId IdType="pubmed">32791114</ArticleId></ArticleIdList></Reference><Reference><Citation>BRASIL M da S. Plano Nacional de Operacionalização da Vacinação contra a Covid-19. 2nd ed. Brasília: 2022. http://bvsms.saude.gov.br/bvs/publicacoes/plano_nacional_operacionalizacao_vacinacao_covid19.pdf</Citation></Reference><Reference><Citation>Baskaran V, Lawrence H, Lansbury LE, Webb K, Safavi S, Zainuddin NI, et al. Co-infection in critically ill patients with COVID-19: An observational cohort study from England. J Med Microbiol. 2021 doi: 10.1099/JMM.0.001350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/JMM.0.001350</ArticleId><ArticleId IdType="pmc">PMC8289210</ArticleId><ArticleId IdType="pubmed">33861190</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui X, Zhao Z, Zhang T, Guo W, Guo W, Zheng J, et al. A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19) J Med Virol. 2021;93:1057–1069. doi: 10.1002/jmv.26398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26398</ArticleId><ArticleId IdType="pmc">PMC7436402</ArticleId><ArticleId IdType="pubmed">32761898</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortés-Telles A, López-Romero S, Figueroa-Hurtado E, Pou-Aguilar YN, Wong AW, Milne KM, et al. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir Physiol Neurobiol. 2021 doi: 10.1016/j.resp.2021.103644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2021.103644</ArticleId><ArticleId IdType="pmc">PMC7910142</ArticleId><ArticleId IdType="pubmed">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotta MC, Kern LB, Polese-Bonatto M, Azevedo TR, Varela FH, Zavaglia GO, et al. Impact of rhinovirus on hospitalization during the COVID-19 pandemic: a prospective cohort study. J Clin Virol. 2022 doi: 10.1016/j.jcv.2022.105197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2022.105197</ArticleId><ArticleId IdType="pmc">PMC9170614</ArticleId><ArticleId IdType="pubmed">35691819</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Q, Yang Q. Risk factors and management of pulmonary infection in elderly patients with heart failure a retrospective analysis. Medicine. 2021 doi: 10.1097/MD.0000000000027238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000027238</ArticleId><ArticleId IdType="pmc">PMC10545257</ArticleId><ArticleId IdType="pubmed">34559121</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardi T, Pintado V, Gomez-Rojo M, Escudero-Sanchez R, Azzam Lopez A, Diez-Remesal Y, et al. Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome. Eur J Clin Microbiol Infect Dis. 2021;40:495–502. doi: 10.1007/s10096-020-04142-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04142-w</ArticleId><ArticleId IdType="pmc">PMC7778834</ArticleId><ArticleId IdType="pubmed">33389263</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180:1345–1355. doi: 10.1001/jamainternmed.2020.3539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.3539</ArticleId><ArticleId IdType="pmc">PMC7364371</ArticleId><ArticleId IdType="pubmed">32667669</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Z, Cheng S, Le J, Huang J, Feng L, Zhang B, et al. Clinical characteristics and co-infections of 354 hospitalized patients with COVID-19 in Wuhan, China: a retrospective cohort study. Microbes Infect. 2020;22:195–9. doi: 10.1016/j.micinf.2020.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2020.05.007</ArticleId><ArticleId IdType="pmc">PMC7233257</ArticleId><ArticleId IdType="pubmed">32425649</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou HC, Papanikolopoulou A, Vassiliu S, Theodoridou K, Nikolopoulou G, Sipsas NV. COVID-19 and respiratory virus co-infections: a systematic review of the literature. Viruses. 2023;15:1–16. doi: 10.3390/v15040865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040865</ArticleId><ArticleId IdType="pmc">PMC10142898</ArticleId><ArticleId IdType="pubmed">37112844</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. 2023;21:195–210. doi: 10.1038/s41579-022-00807-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00807-9</ArticleId><ArticleId IdType="pmc">PMC9574826</ArticleId><ArticleId IdType="pubmed">36253478</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott SJ, Pfotenhauer B, Weiner JJ, Hilleshiem J, Khubbar M, Bhattacharyya S. Respiratory pathogen coinfections in SARS-CoV-2-positive patients in Southeastern Wisconsin: a retrospective analysis. Microbiol Spectr. 2021 doi: 10.1128/spectrum.00831-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.00831-21</ArticleId><ArticleId IdType="pmc">PMC8528126</ArticleId><ArticleId IdType="pubmed">34668725</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen C, Perofsky AC, Burstein R, Famulare M, Boyle S, Prentice R, et al. Trends in Risk factors and symptoms associated with SARS-CoV-2 and Rhinovirus test positivity in King County, Washington, June 2020 to July 2022. JAMA Netw Open. 2022;5:E2245861. doi: 10.1001/jamanetworkopen.2022.45861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.45861</ArticleId><ArticleId IdType="pmc">PMC9856230</ArticleId><ArticleId IdType="pubmed">36484987</ArticleId></ArticleIdList></Reference><Reference><Citation>Varela FH, Sartor ITS, Polese-Bonatto M, Azevedo TR, Kern LB, Fazolo T, et al. Rhinovirus as the main co-circulating virus during the COVID-19 pandemic in children. J Pediatr. 2022;98:579–86. doi: 10.1016/j.jped.2022.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jped.2022.03.003</ArticleId><ArticleId IdType="pmc">PMC9015957</ArticleId><ArticleId IdType="pubmed">35490727</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Z, He J, Wang C, Bao J, Leng T, Chen F. The importance of booster vaccination in the context of Omicron wave. Front. Immunol. 2022 doi: 10.3389/fimmu.2022.977972.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.977972</ArticleId><ArticleId IdType="pmc">PMC9498215</ArticleId><ArticleId IdType="pubmed">36159796</ArticleId></ArticleIdList></Reference><Reference><Citation>dos Santos CVB, Valiati NCM, de Noronha TG, Porto VBG, Pacheco AG, Freitas LP, et al. The effectiveness of COVID-19 vaccines against severe cases and deaths in Brazil from 2021 to 2022: a registry-based study. Lancet Reg Health Am. 2023;20:100465. doi: 10.1016/j.lana.2023.100465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2023.100465</ArticleId><ArticleId IdType="pmc">PMC10010656</ArticleId><ArticleId IdType="pubmed">36936517</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, et al. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med. 2022;386:1532–46. doi: 10.1056/nejmoa2119451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2119451</ArticleId><ArticleId IdType="pmc">PMC8908811</ArticleId><ArticleId IdType="pubmed">35249272</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos GRF, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, et al. Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant. Commun Med. 2022;2:8–11. doi: 10.1038/s43856-022-00141-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-022-00141-4</ArticleId><ArticleId IdType="pmc">PMC9242982</ArticleId><ArticleId IdType="pubmed">35784447</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranzani OT, Hitchings MDT, de Melo RL, de França GV, de Fernandes C, Lind ML, et al. Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil. Nat Commun. 2022;13:1–10. doi: 10.1038/s41467-022-33169-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33169-0</ArticleId><ArticleId IdType="pmc">PMC9537178</ArticleId><ArticleId IdType="pubmed">36202800</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>